Balaji Amines Q1 FY27 Net Profit Jumps to Rs 749m as EBITDA Margin Widens Sharply
AI Market Summary
Balaji Amines reported a sharp Q1FY27 profit increase, driven by a 1,015 bps EBITDA margin expansion and stronger revenue, despite lower volumes, indicating favorable product-mix optimization. The commissioning of India's first commercial-scale DME plant and ongoing downstream capacity additions (NMM, ACN, cyanide derivatives) signal a broader capex cycle. With no directly listed proxy in the provided universe, overall market impact is limited.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-1.26%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Balaji Amines reported a strong Q1 FY27 performance, with consolidated net profit doubling year-on-year to Rs 749 million. Revenue rose 27.37% to Rs 4.56 billion, while EBITDA margin expanded by 1,015 basis points to 25.41%, reflecting a richer mix and better profitability.
The company said volumes were lower from a year ago, but the shift toward higher-margin products more than offset the decline.
Separately, Balaji Amines announced the commissioning of India's first commercial-scale DME plant and said it is progressing capacity expansion across NMM, ACN and downstream cyanide derivatives. For FY26, the company declared a dividend of Rs 11 per share.
